Birth Control Pills Recalled; Mislabeling Could Result in Pregnancy - NBC Boston
National & International News
The day’s top national and international news

Birth Control Pills Recalled; Mislabeling Could Result in Pregnancy

The lot number affected is L600518 with an expiration date of May 2018, although, in addition to placing the pills in the wrong order, the packaging error also made the lot number and expiration date “no longer visible"

Find NBC Boston in your area

Channel 10 on most providers

Channel 60 and 8 Over the Air

    processing...

    NEWSLETTERS

    Birth Control Pills Recalled; Mislabeling Could Result in Pregnancy
    Courtesy FDA
    Birth control pills marketed under the name Mibelas 24-Fe have been recalled after a packaging error resulted in mixed-up hormone and placebo pills.

    A pharmaceutical company is recalling birth control pills mislabeled in a way that could result in an unplanned pregnancy.

    The pills, sold under the name Mibelas 24 F-E, were packaged in the wrong order so the first four days of tablets labeled as active pills are actually placebos.

    The pills were distributed nationally.

    If taken as labeled, consumers will not be receiving the right hormones to prevent conception and could end up pregnant, according to a statement released by the Food and Drug Administration.

    Dramatic Video Shows N. Korean Soldier’s Sprint to Freedom

    [NATL] Dramatic Video Shows N. Korean Soldier’s Sprint to Freedom

    A North Korean soldier made a desperate dash to freedom and was rescued by South Korean soldiers, according to dramatic video released by the U.S.-led U.N. command Wednesday.

    (Published Wednesday, Nov. 22, 2017)

    The lot number affected is L600518 with an expiration date of May 2018, although, in addition to placing the pills in the wrong order, the packaging error also made the lot number and expiration date “no longer visible.”

    Any consumers who have taken the mislabeled pills are advised to call their doctor immediately. The pills should be returned to the pharmacy.

    Consumers with questions can call the manufacturer, Lupin Pharmaceuticals, at 800-399-2561.